Rigel Pharmaceuticals Inc
RIGL· Nasdaq
RIGLRigel Pharmaceuticals Inc
Released Mar 6, 2018, after the close
10-K filed Mar 6, 2018, 65 days after period end · 0001558370-18-001555
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2017 | Q4 2016 | Q4 2015 | Q4 2014 |
|---|---|---|---|---|
| Revenue | $0.00 | — | — | — |
| Net Income | -$25.87M | -$15.59M | — | — |
| EPS Diluted | -$0.18 | -$0.16 |
Rigel Pharmaceuticals Inc · CIK 1034842 · Engraved from SEC EDGAR
| -$0.14 |
| -$0.25 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
